PortfoliosLab logoPortfoliosLab logo
BSX vs. UI
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

BSX vs. UI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Boston Scientific Corporation (BSX) and Ubiquiti Inc. (UI). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, BSX achieves a -50.80% return, which is significantly lower than UI's 6.65% return. Over the past 10 years, BSX has underperformed UI with an annualized return of 7.42%, while UI has yielded a comparatively higher 31.83% annualized return.


BSX

1D
-0.55%
1M
-10.95%
YTD
-50.80%
6M
-49.33%
1Y
-52.97%
3Y*
-2.85%
5Y*
1.80%
10Y*
7.42%

UI

1D
1.20%
1M
-5.42%
YTD
6.65%
6M
5.14%
1Y
54.66%
3Y*
49.97%
5Y*
14.06%
10Y*
31.83%
*Multi-year figures are annualized to reflect compound growth (CAGR)

BSX vs. UI - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
BSX
Boston Scientific Corporation
-50.80%6.75%54.51%24.94%8.92%18.16%-20.50%27.96%42.56%14.61%
UI
Ubiquiti Inc.
6.65%67.72%141.15%-48.23%-9.99%10.83%48.49%91.65%40.69%22.87%

Correlation

The correlation between BSX and UI is 0.08, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.08

Correlation (3Y)
Calculated over the trailing 3-year period

0.14

Correlation (5Y)
Calculated over the trailing 5-year period

0.24

Correlation (10Y)
Calculated over the trailing 10-year period

0.29

Correlation (All Time)
Calculated using the full available price history since Oct 14, 2011

0.28

Over the past year, the correlation between BSX and UI has dropped to 0.08 - well below their long-term average of 0.28, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

BSX:

$70.13B

UI:

$35.66B

EPS

BSX:

$2.38

UI:

$15.56

PE Ratio

BSX:

19.74

UI:

37.84

PEG Ratio

BSX:

0.44

UI:

2.45

PS Ratio

BSX:

3.40

UI:

11.52

PB Ratio

BSX:

2.71

UI:

29.66

Total Revenue (TTM)

BSX:

$20.62B

UI:

$3.10B

Gross Profit (TTM)

BSX:

$14.52B

UI:

$1.42B

EBITDA (TTM)

BSX:

$4.76B

UI:

$1.12B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

BSX vs. UI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BSX
BSX Risk / Return Rank: 22
Overall Rank
BSX Sharpe Ratio Rank: 00
Sharpe Ratio Rank
BSX Sortino Ratio Rank: 22
Sortino Ratio Rank
BSX Omega Ratio Rank: 11
Omega Ratio Rank
BSX Calmar Ratio Rank: 55
Calmar Ratio Rank
BSX Martin Ratio Rank: 11
Martin Ratio Rank

UI
UI Risk / Return Rank: 6767
Overall Rank
UI Sharpe Ratio Rank: 6969
Sharpe Ratio Rank
UI Sortino Ratio Rank: 6767
Sortino Ratio Rank
UI Omega Ratio Rank: 6969
Omega Ratio Rank
UI Calmar Ratio Rank: 6464
Calmar Ratio Rank
UI Martin Ratio Rank: 6565
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BSX vs. UI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Boston Scientific Corporation (BSX) and Ubiquiti Inc. (UI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


BSXUIDifference
Sharpe ratioReturn per unit of total volatility

-2.30

Sortino ratioReturn per unit of downside risk

-3.72

Omega ratioGain probability vs. loss probability

0.67

1.20

-0.54

Calmar ratioReturn relative to maximum drawdown

-0.93

1.01

-1.94

Martin ratioReturn relative to average drawdown

-2.00

2.43

-4.43

BSX vs. UI - Sharpe Ratio Comparison

The current BSX Sharpe Ratio is -1.51, which is lower than the UI Sharpe Ratio of 0.79. The chart below compares the historical Sharpe Ratios of BSX and UI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

BSX vs. UI - Drawdown Comparison

The maximum BSX drawdown since its inception was -89.15%, which is greater than UI's maximum drawdown of -77.49%. Use the drawdown chart below to compare losses from any high point for BSX and UI.


Loading charts...

Drawdown Indicators


BSXUIDifference

Max Drawdown

Largest peak-to-trough decline

-89.15%

-77.49%

-11.66%

Max Drawdown (1Y)

Largest decline over 1 year

-56.62%

-48.52%

-8.10%

Max Drawdown (3Y)

Largest decline over 3 years

-56.62%

-48.52%

-8.10%

Max Drawdown (5Y)

Largest decline over 5 years

-56.62%

-69.44%

+12.82%

Max Drawdown (10Y)

Largest decline over 10 years

-56.62%

-72.21%

+15.59%

Current Drawdown

Current decline from peak

-56.62%

-45.64%

-10.98%

Average Drawdown

Average peak-to-trough decline

-38.76%

-26.55%

-12.21%

Ulcer Index

Depth and duration of drawdowns from previous peaks

26.23%

20.16%

+6.07%

Volatility

BSX vs. UI - Volatility Comparison

Boston Scientific Corporation (BSX) has a higher volatility of 15.84% compared to Ubiquiti Inc. (UI) at 11.58%. This indicates that BSX's price experiences larger fluctuations and is considered to be riskier than UI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


BSXUIDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.84%

11.58%

+4.26%

Volatility (6M)

Calculated over the trailing 6-month period

32.83%

40.18%

-7.35%

Volatility (1Y)

Calculated over the trailing 1-year period

34.77%

62.03%

-27.26%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

25.69%

48.64%

-22.95%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

27.29%

47.98%

-20.69%

Dividends

BSX vs. UI - Dividend Comparison

BSX has not paid dividends to shareholders, while UI's dividend yield for the trailing twelve months is around 0.54%.


PositionTTM20252024202320222021202020192018
BSX
Boston Scientific Corporation
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
UI
Ubiquiti Inc.
0.54%0.51%0.72%1.72%0.88%0.65%0.50%0.58%0.50%

Financials

BSX vs. UI - Financials Comparison

This section allows you to compare key financial metrics between Boston Scientific Corporation and Ubiquiti Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.001.00B2.00B3.00B4.00B5.00B20222023202420252026
5.20B
788.20M
(BSX) Total Revenue
(UI) Total Revenue
Values in USD except per share items

BSX vs. UI - Profitability Comparison

The chart below illustrates the profitability comparison between Boston Scientific Corporation and Ubiquiti Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

30.0%40.0%50.0%60.0%70.0%20222023202420252026
69.4%
47.0%
Portfolio components
BSX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.

UI - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Ubiquiti Inc. reported a gross profit of 370.71M and revenue of 788.20M. Therefore, the gross margin over that period was 47.0%.

BSX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.

UI - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Ubiquiti Inc. reported an operating income of 290.82M and revenue of 788.20M, resulting in an operating margin of 36.9%.

BSX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.

UI - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Ubiquiti Inc. reported a net income of 233.91M and revenue of 788.20M, resulting in a net margin of 29.7%.


Frequently Asked Questions


BSX and UI have a correlation of 0.08, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

BSX has higher volatility (15.84%) compared to UI (11.58%). In terms of maximum drawdown, BSX dropped -89.15% vs UI's -77.49%.

UI currently has the higher Sharpe Ratio (0.79 vs -1.51), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for BSX and UI

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer